ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1876

A Prospective Observational Cohort Study and Systematic Review of 40 Patients with Mouth and Genital Ulcers with Inflamed Cartilage (MAGIC) Syndrome

Yiming Luo1, Ertugrul Bolek1, Kaitlin Quinn2, Kristina Wells3, Emily Rose4, Emily Rominger1, Levent Kilic5, Omer Karadag6, Cindy Clark1, Alicia Livinski1, Peter Grayson7 and Marcela Ferrada1, 1National Institutes of Health, Bethesda, MD, 2National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Washington, DC, 3National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 4Case Western, Cleveland Heights, OH, 5Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, 6Hacettepe University, Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Ankara, Turkey, 7National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD

Meeting: ACR Convergence 2021

Keywords: Behçet's Syndrome, cartilage, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster II (1862–1888)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome is a rare and poorly understood entity with clinical features of both relapsing polychondritis (RP) and Behcet’s disease (BD). This study characterized the clinical features of MAGIC syndrome and derived a disease definition for use in future studies.

Methods: Adult patients within an ongoing prospective, observational cohort study in RP were clinically assessed for MAGIC syndrome. A systematic review was conducted to identify additional cases of MAGIC syndrome. Clinical characteristics were compared between the pooled cases of MAGIC syndrome and cases of non-MAGIC RP. The performance characteristics of three different criteria to classify MAGIC syndrome were evaluated.

Results: Of the 96 patients with RP in the cohort study, 13 (14%) had MAGIC syndrome. The systematic review identified 27 additional MAGIC syndrome cases in literature. Patients reported in the literature were more likely to have ear chondritis (96% vs 54%, p < 0.01) and less likely to have nasal chondritis (63% vs 100%, p = 0.02), airway chondritis (19% vs 69%, p < 0.01), and costochondritis (7% vs 85%, p < 0.01) when compared with patients in the cohort study. When comparing clinical manifestations seen in BD, patients with MAGIC reported in the literature had a greater prevalence of BD-related cutaneous involvement (erythema nodosum, pseudofolliculitis or pathergy) than patients in the cohort study (48% vs 8 %, p = 0.01). Raynaud’s phenomenon was reported in 54% patients in the cohort study but was not described in any cases of MAGIC syndrome reported in literature. Anti-collagen II antibodies were not reported in any MAGIC syndrome cases in literature.

Pooling the 40 cases together and comparing them with non-MAGIC RP, there was significantly higher prevalence of almost all BD-related features in patients with MAGIC syndrome, including BD-related ocular involvement (uveitis or retinal vasculitis (, 28% vs 4%, p < 0.01), BD-related cutaneous involvement (erythema nodosum, pseudofolliculitis or pathergy (, 35% vs 1%, p < 0.01), GI involvement (23% vs 4%, p < 0.01) and CNS involvement (8% vs 0, p = 0.04). There was also a higher prevalence of aortitis (23% vs 1%, p < 0.01) and Raynaud’s phenomenon (54% vs 11%, p < 0.01) and anti-collagen II antibodies (50% vs 9%, p = 0.04) in MAGIC syndrome. Fulfillment of either McAdam’s or Damiani’s Criteria for RP plus the International Criteria for Behçet's Disease (ICBD) had excellent sensitivity (98%) to classify cases of MAGIC syndrome. Use of presence of oral and genital ulcers to define MAGIC syndrome had lower sensitivity (88%). In contrast, the International Study Group (ISG) criteria performed poorly for defining MAGIC syndrome with low sensitivity (43%).

Conclusion: MAGIC syndrome can be diagnosed in a substantial proportion of patients with RP. These patients have features of RP, BD, and other unique features such as aortitis, Raynaud’s phenomenon and anti-collagen II antibodies. Fulfillment of McAdam’s or Damiani’s criteria for RP and the ICBD criteria for BD can be used to define MAGIC syndrome in future research studies.


Disclosures: Y. Luo, None; E. Bolek, None; K. Quinn, None; K. Wells, None; E. Rose, None; E. Rominger, None; L. Kilic, None; O. Karadag, Omer Karadag has received research grants from Roche, Pfzer as study investigator and received consulting fees from Celltrion., 6; C. Clark, None; A. Livinski, None; P. Grayson, None; M. Ferrada, None.

To cite this abstract in AMA style:

Luo Y, Bolek E, Quinn K, Wells K, Rose E, Rominger E, Kilic L, Karadag O, Clark C, Livinski A, Grayson P, Ferrada M. A Prospective Observational Cohort Study and Systematic Review of 40 Patients with Mouth and Genital Ulcers with Inflamed Cartilage (MAGIC) Syndrome [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/a-prospective-observational-cohort-study-and-systematic-review-of-40-patients-with-mouth-and-genital-ulcers-with-inflamed-cartilage-magic-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-prospective-observational-cohort-study-and-systematic-review-of-40-patients-with-mouth-and-genital-ulcers-with-inflamed-cartilage-magic-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology